首页> 外国专利> CEPHALOSPORIN DERIVATIVES HAVING IMPROVED ANTI-MICROBIAL ACTIVITY, PARTICULARLY, FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS(MRSA) STRAIN, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND MANUFACTURING PROCESS THEREOF

CEPHALOSPORIN DERIVATIVES HAVING IMPROVED ANTI-MICROBIAL ACTIVITY, PARTICULARLY, FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS(MRSA) STRAIN, ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND MANUFACTURING PROCESS THEREOF

机译:头孢菌素衍生物对耐甲氧西林金黄色葡萄球菌(MRSA)菌株,其药学上可接受的盐和制造方法的抗微生物活性特别是得到改善

摘要

PURPOSE: Cephalosporin derivatives, its pharmaceutically acceptable salts and a manufacturing process thereof are provided, which cephalosporin derivatives have improved anti-microbial activity, particularly, for methicillin-resistant Staphylococcus aureus(MRSA) strain, so that they can be useful for antibiotics. CONSTITUTION: The cephalosporin derivatives represented by formula (I), or pharmaceutically acceptable salts thereof are provided, wherein X, Y and Z are the same or different, and independently hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy, C1-6 halogenoalkyl, C1-6 alkoxy alkyl or C3-6 cycloalkyl; R1 is an isoxazol compound in which the 3-site is substituted with a compound of formula (A), wherein Q is a substituent useful for cephalosporin-based compound, and is selected from hydrogen, halogen, hydroxyl, mercapto, cyano, carboxy, carboxylic acid, ester, carbamoyloxy, carbamoyl, N,N-dimethylcarbamoyl, C1-4 alkyl, C1-4 alkyloxy, halogen substituted alkyl, aryl or hetero ring substituent; and R2 is hydrogen, an ester-forming group as an ester of carboxy group, salt-forming atom or carboxy-protecting group. The process for preparing the cephalosporin derivatives represented by formula (I), or pharmaceutically acceptable salts thereof comprises reacting an ilide compound of formula (VI) with an aldehyde compound of formula (VII) in the presence of base and organic solvent at -40 to 25 deg. C.
机译:目的:提供一种头孢菌素衍生物,其药学上可接受的盐及其制备方法,该头孢菌素衍生物具有改善的抗微生物活性,特别是对耐甲氧西林的金黄色葡萄球菌(MRSA)菌株具有抗微生物活性,因此它们可用于抗生素。组成:提供了由式(I)表示的头孢菌素衍生物或其药学上可接受的盐,其中X,Y和Z相同或不同,并且独立地为氢,卤素,C 1-6烷基,C 1-6烷氧基,C 1- 6个卤代烷基,C 1-6烷氧基烷基或C 3-6环烷基; R1是异恶唑化合物,其中3-位被式(A)化合物取代,其中Q是对头孢菌素类化合物有用的取代基,并且选自氢,卤素,羟基,巯基,氰基,羧基,羧酸,酯,氨基甲酰氧基,氨基甲酰基,N,N-二甲基氨基甲酰基,C 1-4烷基,C 1-4烷氧基,卤素取代的烷基,芳基或杂环取代基; R 2为氢,作为羧基的酯的成酯基,成盐原子或羧基保护基。式(I)代表的头孢菌素衍生物或其药学上可接受的盐的制备方法包括在碱和有机溶剂的存在下,于-40℃使式(VI)的酰亚胺化合物与式(VII)的醛化合物反应。 25度C。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号